| |
| |
|
| Insider
Information: |
Lindahl Richard S |
| Relationship: |
EVP, Chief Financial O... |
| City: |
Reston |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
158,742 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$881,018 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
158,742 |
|
|
| Total
Value |
$881,018 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
 7.6%
|
2.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CEB Inc |
CEB |
Chief Financial Officer |
2017-04-05 |
0 |
2010-07-12 |
0 |
Premium* |
|
|
Emergent Biosolutions Inc. |
EBS |
EVP, Chief Financial O... |
2024-03-01 |
158,742 |
2018-05-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2015-02-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,056 |
15,275 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2015-02-20 |
4 |
D |
$79.19 |
$147,689 |
D/D |
(1,865) |
13,410 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2015-03-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,208 |
15,618 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2015-03-30 |
4 |
D |
$80.02 |
$143,556 |
D/D |
(1,794) |
18,769 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2015-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,945 |
20,563 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2015-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
20,519 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2016-02-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,027 |
23,546 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2016-03-28 |
4 |
D |
$62.52 |
$54,142 |
D/D |
(866) |
29,025 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2016-03-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,345 |
29,891 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2016-04-25 |
4 |
D |
$64.85 |
$48,248 |
D/D |
(744) |
30,333 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2016-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,052 |
31,077 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2017-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,255 |
32,588 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2017-03-27 |
4 |
D |
$78.90 |
$58,702 |
D/D |
(744) |
37,852 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2017-03-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,008 |
38,596 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2017-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(44,285) |
0 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2017-04-05 |
4 |
D |
$78.85 |
$98,799 |
D/D |
(1,253) |
44,285 |
0 |
- |
|
| CEB |
CEB Inc |
Chief Financial Officer |
• – – |
2017-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,686 |
45,538 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2018-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,534 |
11,534 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,162 |
21,696 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2019-05-08 |
4 |
D |
$47.49 |
$36,045 |
D/D |
(759) |
20,937 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,207 |
33,144 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2020-02-26 |
4 |
D |
$59.91 |
$36,545 |
D/D |
(610) |
32,534 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2020-05-08 |
4 |
D |
$79.25 |
$57,694 |
D/D |
(728) |
31,806 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-09 |
4 |
D |
$123.45 |
$311,341 |
D/D |
(2,522) |
31,779 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
34,301 |
0 |
- |
|
72 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
